Table 4.
Prevalence of antimicrobial resistance to common parenteral antibiotics used in treating UTIs in Ghana among the top uropathogens isolated from urine samples of patients with UTIs at MDS Lancet Laboratories, Ghana, from 2017 to 2021.
| Organism | Ak | Caz | Cro | Mem | Piptaz | Tige |
|---|---|---|---|---|---|---|
| n (%) 1 | n (%) 1 | n (%) 1 | n (%) 1 | n (%) 1 | n (%) 1 | |
| E. coli | 461 (3.1) | 7147 (48.62) | 7362 (50.1) | 42 (0.3) | 7148 (48.6) | 252 (1.7) |
| Klebsiella spp. | 116 (3.7) | 1802 (57.9) | 1834 (58.9) | 56 (1.8) | 1803 (57.9) | 173 (5.6) |
| Proteus spp. | 3 (0.3) | 46 (4.1) | 46 (4.1) | 3 (0.3) | 17 (39.5) | N/A |
| Acinetobacter spp. | 2 (4.2) | 17 (35.4) | N/A | 1 (2.1) | 14 (29.2) | N/A |
| Pseudomonas spp. | 21 (21) | 30 (30) | N/A | 19 (19) | 27 (27.0) | N/A |
1 Percentages calculated with the total number of urine samples that yielded the particular species as the denominator. Antibiotics in Green belong to the Access group, those in Yellow belong to the Watch group, and those in Red belong to the Reserve Group as per the WHO AWaRe classification 2021. Cro: Ceftriaxone; Cp: Cefepime; Piptaz: Piperacillin tazobactam; Caz: Ceftazidime; Mem: Meropenem; Ak: Amikacin; Vanc: Vancomycin; Tige: Tigecycline; UTI—urinary tract infection; GNB—gram-negative bacilli; N/A—not applicable.